Redcentric Share Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Redcentric in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Redcentric stock.
View analyst ratings for Redcentric or view top-rated stocks.

Wall Street analysts have given Redcentric a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Redcentric wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Redcentric's stock was trading at GBX 99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RCN stock has increased by 33.3% and is now trading at GBX 132.
View which stocks have been most impacted by COVID-19.

Redcentric announced a dividend on Thursday, July 15th. Shareholders of record on Thursday, August 5th will be paid a dividend of GBX 2.40 per share on Friday, September 17th. This represents a yield of 1.89%. The ex-dividend date of this dividend is Thursday, August 5th. This is a boost from Redcentric's previous dividend of GBX 1.20. The official announcement can be seen at this link.
View Redcentric's dividend history.

Redcentric pays an annual dividend of GBX 0.01 per share and currently has a dividend yield of 2.64%. The dividend payout ratio of Redcentric is 0.14%. This payout ratio is at a healthy, sustainable level, below 75%.
View Redcentric's dividend history.

1 Wall Street analysts have issued twelve-month price objectives for Redcentric's shares. Their forecasts range from GBX 190 to GBX 190. On average, they anticipate Redcentric's share price to reach GBX 190 in the next twelve months. This suggests a possible upside of 43.9% from the stock's current price.
View analysts' price targets for Redcentric or view top-rated stocks among Wall Street analysts.

Some companies that are related to Redcentric include GFT Technologies (GFT), First Derivatives (FDP), iEnergizer (IBPO), Quisitive Technology Solutions (QUIS), Sylogist (SYZ), The Panoply (TPX), Banxa (BNXA), Pivot Technology Solutions (PTG), K3 Business Technology Group (KBT), Nasstar (NASA), Scisys Group (SSY), Actual Experience (ACT), Corero Network Security (CNS), Smart Employee Benefits (SEB) and Mode Global (MODE).
View all of RCN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Redcentric investors own include Nasstar (NASA), Zoom Video Communications (ZM), Akebia Therapeutics (AKBA), Community Bank System (CBU), Eddie Stobart Logistics plc (ESL.L) (ESL), Premier Oil (PMO), Ruth's Hospitality Group (RUTH), The Toro (TTC), Baxter International (BAX) and The Boeing (BA).

Redcentric trades on the London Stock Exchange (LON) under the ticker symbol "RCN."

Shares of RCN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of RCN stock can currently be purchased for approximately GBX 132.

Redcentric has a market capitalization of £206.11 million and generates £91.40 million in revenue each year.

Redcentric employs 430 workers across the globe.

The official website for Redcentric is www.redcentricplc.com.

Redcentric is headquartered at Central House Beckwith Knowle, Otley Road, HARROGATE, HG3 1UG, United Kingdom.

Redcentric's mailing address is Central House Beckwith Knowle, Otley Road, HARROGATE, HG3 1UG, United Kingdom. The company can be reached via phone at +44-1423-850000.